Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;130(6):1316-1325.
doi: 10.1002/jso.27842. Epub 2024 Aug 29.

New insights in the management of pseudomyxoma peritonei

Clément Pastier  1 , I H J T De Hingh  2 , Diane Goéré  1
Affiliations
Review

New insights in the management of pseudomyxoma peritonei

Clément Pastier et al. J Surg Oncol. 2024 Nov.

Abstract

While a rare entity, peritoneal pseudomyxoma treatment evolves. Decision-making criteria improve with imaging development and exploratory laparoscopy. Surgery remains at the core of the therapeutic strategy whatever disease progression. Complete cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) is standard of care. Iterative cytoreduction or debulking is sometimes justified. Intraperitoneal chemotherapy modalities change with early postoperative HIPEC or pressurized intraperitoneal aerosol chemotherapy. Systemic or local treatment such as new chemo/immuno-therapies or BromAc should improve outcomes. Expertise and multicentric cooperation are more than ever needed.

Keywords: appendix neoplasm; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; peritoneal pseudomyxoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Arnason T, Kamionek M, Yang M, Yantiss RK, Misdraji J. Significance of proximal margin involvement in low‐grade appendiceal mucinous neoplasms. Arch Pathol Lab Med. 2015;139(4):518‐521. 10.5858/arpa.2014-0246-OA - DOI - PubMed
    1. Smeenk RM, Van Velthuysen MLF, Verwaal VJ, Zoetmulder FAN. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196‐201. 10.1016/j.ejso.2007.04.002 - DOI - PubMed
    1. Sugarbaker PH. Treatment of pseudomyxoma peritonei from non‐appendiceal primary sites. In: Canbay E, ed. Unusual Cases in Peritoneal Surface Malignancies. Springer International Publishing; 2017:23‐46. 10.1007/978-3-319-51523-6_3 - DOI
    1. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12(3):585‐603. 10.1016/S1055-3207(03)00026-7 - DOI - PubMed
    1. Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30(5):551‐559. 10.1097/01.pas.0000202039.74837.7d - DOI - PubMed

MeSH terms